𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Initial clinical trials with methyl-ccnu 1-(2-chloroethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (meccnu)

✍ Scribed by Robert C. Young; Michael D. Walker; George P. Canellos; Philip S. Schein; Bruce A. Chabner; Vincent T. Devita

Publisher
John Wiley and Sons
Year
1973
Tongue
English
Weight
434 KB
Volume
31
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Physiologic disposition of 1-(2-chloroet
Physiologic disposition of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (MeCCNU) in man
✍ Robert W. Sponzo; Vincent T. Devita; Vincent T. Oliverio πŸ“‚ Article πŸ“… 1973 πŸ› John Wiley and Sons 🌐 English βš– 466 KB πŸ‘ 2 views

The physiologic disposition of radioactive-labelled CCNU and MeCCNU was studied in patients receiving these drugs as part of their early clinical trial. CCNU was given orally in doses of 30-100 mg/m2 a n d MeCCNU in doses of 120-290 mg/m?. With both drugs, significant plasma levels of radioactivity

Copolymerization of methyl acrylate with
Copolymerization of methyl acrylate with styrene using triphenylstibonium 1,2,3,4-tetraphenylcyclopentadienylide as a novel radical initiator
✍ Upasana Mohan; Anuradha Varshney πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 124 KB πŸ‘ 1 views

## Abstract The free‐radical copolymerization of methyl acrylate with styrene initiated by triphenylstibonium 1,2,3,4‐tetraphenylcyclopentadienylide under nitrogen blanket at (60 Β± 0.1)Β°C in 1,4,dioxane for 2 h has been carried out. The kinetic expression is __R~p~__ ∝ [I]^0.14^ [MA]^0.70^ [Sty]^0.